Muscular Dystrophy, Emery-Dreifuss: Clinical Trials

6 trials for Muscular Dystrophy, Emery-Dreifuss, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 3 recruiting. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Recruiting 1

Follow Muscular Dystrophy, Emery-Dreifuss: new trials by email Literature Review of Muscular Dystrophy, Emery-Dreifuss trials Research Report on Muscular Dystrophy, Emery-Dreifuss

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Modifying Factors in Striated Muscle Laminopathies
Skin Biopsy, Muscle biopsy - Laminopathies, Emery Dreifuss Muscular Dystrophy 2
Not applicableRecruitingInstitut National de la Santé Et de la Recherche Médicale, France402022-09-082026-03-04
Changes of Motor Function Tests in Congenital Myopathy Subjects Treated With Oral Salbutamol as Compared to no Treatment
Salbutamol (as Salbutamol Sulfate) 2 Mg Oral Tablet, Salbutamol Only Product in Oral Dose Form - Congenital Myopathy, Neuromuscular Diseases
Not applicableCompletedVastra Gotaland Region182021-10-252025-06-19
A Model for Healthy Aging: Moscow Centenarians (AGE-100)
Aging
CompletedPirogov Russian National Research Medical University1002016-10-012021-03-23
Observatoire Des Patients Atteints de Laminopathies et Emerinopathies (Observatory for PAtients With Laminopathies and Emerinopathies)
Laminopathies, Emerinopathies
RecruitingPitié-Salpêtrière Hospital8002013-07-112026-09-21
Congenital Muscle Disease Study of Patient and Family Reported Medical Information
Congenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) Deficiency, Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy and Abnormal Glycosylation of Dystroglycan With Severe Epilepsy)
RecruitingCure CMD40002009-09-012021-08-09
Clinical Studies of Progeria
Progeria
CompletedNational Human Genome Research Institute (NHGRI)152004-10-142019-11-15

Narrower conditions

Autosomal Emery-Dreifuss Muscular Dystrophy (4)  ·  Laminopathies (2)  ·  Musculoskeletal Diseases (2)  ·  Myotonia Congenita (2)  ·  Neuromuscular Diseases (2)  ·  Aging, Premature (1)  ·  Atherosclerosis (1)  ·  Cardiomyopathy, Dilated (1)  ·  Epilepsy (1)  ·  Intellectual Disability (1)  ·  Lipodystrophy (1)  ·  Muscular Dystrophies (1)  ·  Muscular Dystrophies, Limb-Girdle (1)  ·  Muscular Dystrophy, Congenital, Due To Integrin Alpha-7 Deficiency (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (6)  ·  Genetic Diseases, Inborn (6)  ·  Muscular Diseases (6)  ·  Muscular Disorders, Atrophic (6)  ·  Nervous System Diseases (6)  ·  Muscular Dystrophies (5)  ·  Musculoskeletal Diseases (4)  ·  Neuromuscular Diseases (4)  ·  Genetic Diseases, X-Linked (3)  ·  Cardiovascular Diseases (2)  ·  Heredodegenerative Disorders, Nervous System (2)  ·  Laminopathies (2)  ·  Myotonic Disorders (2)  ·  Neurodegenerative Diseases (2)

Interventions

Albuterol (1)  ·  Dosage Forms (1)  ·  Tablets (1)

Sponsors

Cure CMD (1)  ·  Institut National de la Santé Et de la Recherche Médicale, France (1)  ·  National Human Genome Research Institute (NHGRI) (1)  ·  Pirogov Russian National Research Medical University (1)  ·  Pitié-Salpêtrière Hospital (1)  ·  Vastra Gotaland Region (1)

Countries

France (2)  ·  United States (2)  ·  Russia (1)  ·  Sweden (1)

Top investigators

Gisele Bonne, PhD (1)  ·  Gustavo Dziewczapolski, PhD (1)  ·  Karim Wahbi, MD, PhD (1)  ·  Niklas Darin, M.D (1)  ·  Olga N. Tkacheva, Professor (1)  ·  Rabah Ben Yaou, MD (1)  ·  William A Gahl, M.D. (1)

Results publications

PMID 18256394, PMID 31155932, PMID 41790128

NIH funding

2019 (1)